by John Conrad | Oct 31, 2022 | iBIO in the News
Illinois’ bioscience industry has seen major growth in recent years as government grants and private investors have pumped money into the sector, according to a new report. But a shaky economy and venture-capital slowdown this year will likely hamstring...
by John Conrad | Sep 19, 2022 | iBIO in the News
Although Chicago is the third largest city in the United States, when it comes to its position as a leading biotech hub, the second city ranks far below many other U.S. locations. That is starting to change, however, as new companies move into this heart of...
by John Conrad | Jan 10, 2020 | Member News
Trammell Crow Company (TCC), one of the largest commercial real estate developers in the United States, is developing Fulton Labs, a best-in-class life sciences laboratory and office building in Chicago’s Fulton Market neighborhood. The new 400,000-square-foot...
by John Conrad | Sep 26, 2019 | Policy News
This Oped was originally published in Crain’s Chicago Business on September 6, 2019 John Pletz’s article (“Will these startups help biotech take root in Chicago?” Aug. 9) highlights a shift in the Illinois biotech community and underscores the need...
by John Conrad | May 18, 2019 | Member News
Sterling Bay, one of Chicago’s largest real estate development and investment firms, announced plans today to create Prysm Life Sciences, a catalyst for a sustainable and scalable life science community in Chicago. Citing its transformation of the West Loop and Fulton...
